StockData
Apimeds Pharmaceuticals US, Inc. logo

Apimeds Pharmaceuticals US, Inc. (APUS) stock

APUSNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 1/30
$1.95−0.09 (-4.41%)

Close on Nov 17, 2026Market cap $2.94MP/E –Yield –

Apimeds Pharmaceuticals US market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Apimeds Pharmaceuticals US's market cap was $3.56M on Nov 11, 2026, against $36.47M a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$3.56M-82.7%
2025Dec 31, 2025$20.62M–

More Apimeds Pharmaceuticals US figures

See a number that looks wrong?